ALLIE GORDON: Open Payments
NPI 1053813303 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$798 in 39 payments from 12 companies in 2025. Trend: 2023 $522 · 2024 $818 · 2025 $798
Food & beverage: $798
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $145 |
| Vanda Pharmaceuticals Inc. | 11 | $143 |
| Axsome Therapeutics, Inc. | 4 | $104 |
| ABBVIE INC. | 5 | $100 |
| Alkermes, Inc. | 3 | $60 |
| Lundbeck LLC | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Tris Pharma Inc | 2 | $34 |
| Bausch Health US, LLC | 2 | $32 |
Products named: SPRAVATO, Auvelity, VRAYLAR, REXULTI, HETLIOZ, FANAPT, LYBALVI, CAPLYTA.
Industry payments across KY — which companies pay providers there.
